Ledger.Open graph →
SEC Form D · filed June 23, 2015

Nexcida Therapeutics, Inc

Offering
$21.3M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Other
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Brent R. Ahrens · Menlo Park, CADirectorPatrick Heron · Canton, MADirectorMark C. Jensen · Scottsdale, AZDirectorGeoff Reed · Burnaby, British Columbia, CanadaDirectorYigong Ge · Menlo Park, CADirectorChen Yu · Palo Alto, CADirectorDavid Socks · Seattle, WAExec · Director · PromoterJames C. Jeddeloh · Scottsdale, AZDirectorMichael W. Mccormick · Scottsdale, AZDirectorYigong Ge · Menlo Park, CADirectorChen Yu · Palo Alto, CADirectorDavid Socks · Menlo Park, CAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗